Anne Coleman
Internal Medicine · Richardson, TXNPI 1114938826
Payments from drug & device makers
Across 161 payments — averaging $23.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$713
- AstraZeneca$605
- AbbVie$454
- Abbott$440
- Idorsia Pharmaceuticals US Inc$215
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$183
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,795100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 23 | $713 |
| AstraZeneca | 22 | $605 |
| AbbVie(2 entities) | 22 | $454 |
| Abbott | 19 | $440 |
| Idorsia Pharmaceuticals US Inc | 8 | $215 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $183 |
| IBSA Pharma Inc. | 11 | $179 |
| Dexcom, Inc. | 3 | $142 |
| Pfizer | 8 | $141 |
| Therapeuticsmd, Inc. | 3 | $135 |
| Bausch Health US, LLC | 6 | $82 |
| Sanofi-aventis U.S. LLC | 4 | $73 |
| Corcept Therapeutics | 3 | $73 |
| Boehringer Ingelheim | 3 | $63 |
| Exact Sciences | 2 | $39 |
| Biohaven Pharmaceuticals, Inc. | 1 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $33 |
| Romark Laboratories, LC | 3 | $28 |
| Novo Nordisk | 2 | $28 |
| Genentech USA, Inc. | 1 | $20 |
| Millicent US Inc | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$350
- ZEPBOUND$244
- FREESTYLE LIBRE 3$137
- QULIPTA$124
- UBRELVY$124
- QUVIVIQ$115
- DEXCOM G6 TRANSMITTER$106
- BIJUVA$105
- JARDIANCE$103
- MOUNJARO$101
How this compares
$3,795 in reported general payments places this provider in the 85th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 29 | $18,501 |
| MounjaroTirzepatide | 17 | $17,006 |
| TrintellixVortioxetine Hydrobromide | 16 | $12,818 |
| OzempicSemaglutide | 12 | $11,386 |
| TrulicityDulaglutide | 11 | $10,322 |
| Armour ThyroidThyroid,pork | 26 | $3,425 |
| Estradiol (Twice Weekly)Estradiol | 22 | $1,909 |
| Liothyronine Sodium | 32 | $1,682 |
| Levothyroxine Sodium | 116 | $1,553 |
| PaxlovidNirmatrelvir/Ritonavir | 12 | $1,429 |
| ProgesteroneProgesterone, Micronized | 24 | $1,370 |
| Duloxetine Hcl | 48 | $1,158 |
| Nystatin | 14 | $1,142 |
| Np ThyroidThyroid,pork | 12 | $1,052 |
| Bupropion XlBupropion Hcl | 33 | $916 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $713 | $27,32928 claims |
| Boehringer IngelheimJardiance | $63 | $18,50129 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $14 | $12,81816 claims |
| Novo NordiskOzempic | $28 | $11,38612 claims |
| AbbVieArmour Thyroid | $454 | $3,42526 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $33 | $1,553116 claims |
| PfizerPaxlovid | $141 | $1,42912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Richardson
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.